Cystic fibrosis

From The School of Biomedical Sciences Wiki
(Difference between revisions)
Jump to: navigation, search
Line 17: Line 17:
 
Class IV: [[Conductance Defect|Conductance Defect]]  
 
Class IV: [[Conductance Defect|Conductance Defect]]  
  
Class V: [[Reduced Protein Synthesis|Reduced Protein Synthesis]]
+
Class V: [[Reduced Protein Synthesis|Reduced Protein Synthesis]]  
 +
 
 +
 
 +
 
 +
== Approaches to Treatment ==
 +
 
 +
==== Lung Function ====
 +
 
 +
[[Physiotherapy and mucolytics|Physiotherapy and mucolytics]]
 +
 
 +
Oral and Inhaled [[Antibotics|Antibotics]]
 +
 
 +
[[Anti-Inflammatory|Anti-Inflammatory Drugs]]
 +
 
 +
[[Transplant|Lung Transplant]]
 +
 
 +
[[Gene therapy|Gene Therapy]]
 +
 
 +
[[Pharmacotherapy|Pharmacotherapy]]
 +
 
 +
[[Alternative Channel Therapy|Alternative Channel Therapy]]
 +
 
 +
 
 +
 
 +
===== Pancreatic Function =====
 +
 
 +
[[Pancreatic Enzyme Replacement|Pancreatic Enzyme Replacement]]
 +
 
 +
Nutrional Regime

Revision as of 11:38, 8 November 2010

Contents

Cystic Fibrosis

Cystic Fibrosis is an autosomal recessive disease located on chromosome 7. Cystic Fibrosis is caused by a mutation to the CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) channel. The most common mutation is ΔF508, accounting for 70% of mutations in the Caucasin UK population, in which the triplet code for the amino acid phenylalanine is deleted, disrupting Cl- transport. This mutation belongs to the Class II group of mutations causing Cystic Fibrosis.


Classes of CFTR Mutations


Class I: Premature Stop Codons

Class II: Abnormal Processing

Class III: Altered Regulation

Class IV: Conductance Defect

Class V: Reduced Protein Synthesis

 

Approaches to Treatment

Lung Function

Physiotherapy and mucolytics

Oral and Inhaled Antibotics

Anti-Inflammatory Drugs

Lung Transplant

Gene Therapy

Pharmacotherapy

Alternative Channel Therapy


Pancreatic Function

Pancreatic Enzyme Replacement

Nutrional Regime

Personal tools
Namespaces
Variants
Actions
Navigation
Toolbox